Form S-4
Please address and highlight early in this section the changes in voting power and equity stake of current Atlas public stockholders as a result of the Business Combination, disclosing the percentage equity ownership and voting power current Archer shareholders will hold in New Archer. Make similar changes to the Summary.
On behalf of Atlas Crest Investment Corp. (“Atlas Crest”), we are providing this letter in response to the comment below from the Staff received by letter dated April 2, 2021 (the “Comment Letter”) relating to the Registration Statement on Form S-4 (File No. 333-254007) originally filed on March 8, 2021 (the “Registration Statement”). For the convenience of the staff (the “Staff”), we have recited the prior comment from the Comment Letter from the Staff in italicized type and have followed the comment with Atlas “5.One letter for all the questions, without numbered answers. Read the replyRest of the letter
Please provide us with additional detail explaining the basis for the grant date fair value of the common stock underlying stock options issued during 2020 and, if applicable, 2021. As part of your response, include detail regarding options issued by date of grant and explain any factors that resulted in changes in valuation. In addition, explain the reasons for differences between the valuations of your common stock at the grant date for options you issued and the valuation determined as part of your proposed business combination transaction.” Historical Fair Value Determination and Methodology As stated in the Registration Statement, stock-based compensation expense related to stock options granted to employees is measured at the date of grant based on the fair value of the award. The Registration Statement describes the use of the Black-Scholes option-pricing model by Archer Aviation Inc. (“Archer”) for these purposes and describes and quantifies the significant assumptions used. Board”) intended all options granted to be exercisable at a price per share no less than the per share fair value of the common stock of Archer (the “Common Stock”) underlying those options on the date of grant. The estimated fair value of the Common Stock underlying stock options was determined at each grant date by the Archer Board and was supported by periodic independent third-party valuations. The valuations of the Common Stock were determined in accordance with the guidelines outlined in the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation as described herein and on pages 194 and 195 of the Registration Statement. As discussed below, the methodologies used by Archer with the assistance of the third-party valuation firm to determine the fair value of the Common Stock through September 17, 2020 included the market approach (subject company transaction method) and an Option Pricing Method1 (“OPM”) to allocate the value of Archer. With the January 12, 2021 valuation, the value of Archer was derived utilizing a hybrid approach, which consisted of a combination of an OPM and probability weighted expected return method (“PWERM”) to derive the concluded value. The PWERM consisted of an exit scenario, such as a SPAC, based on a non-binding letter of intent from Atlas Crest. In addition, a stay private scenario value estimated using the income approach (discounted cash flow method) and market approach (guideline public company method) from which derived value was allocated using an OPM. The following table summarizes the valuation dates, methods and resulting valuations used for the accounting for share-based payment in 2019, 2020 and 2021: The assumptions used in each valuation model to determine the fair value of the Common Stock as of the grant date of each option are based on numerous objective and subjective considerations, combined with management judgment, including but not limited to the following: ● Archer’s stage of development and business strategy, including the status of research and development efforts of and the material risks related to Archer’s business and industry; results of operations and financial position, including its levels of available capital resources; ● the valuation of publicly traded companies in the UAM industry, as well as recently completed mergers and acquisitions of peer companies; lack of marketability of its common stock as a private company; prices of Archer’s convertible preferred stock sold to investors in arm’s length transactions and the rights, preferences and privileges of its convertible preferred stock relative to those of its common stock; likelihood of achieving a liquidity event for the holders of common stock, such as an initial public offering or a sale of Archer, given prevailing market conditions; The option pricing method can be based on either a binomial or Black-Scholes option pricing model, as was selected. The option pricing method assumes a liquidity event involving some type of transaction, whether it would be a sale, transfer, merger, IPO, or dissolution, of Archer . Under any option pricing theory, various inputs are needed in order to derive value, including the value of the underlying asset, the exercise price, the underlying asset 's estimated volatility, the term, and an appropriate discount rate. ● trends and developments in Archer’s industry; and ● external market conditions affecting the UAM industry. Archer entered into a preferred stock purchase agreement (the “Series A Preferred Stock Purchase Agreement”) with existing and new investors in multiple tranches between July 2020 and October 2020 to raise a total of $55.7 million, $50.4 million of which was cash and $5.3 million of which was the cancellation of convertible promissory notes, at $1.2046 per share (such transaction, the “Series A Financing”). The Series A Financing was considered to be an arms-length transaction due to the material participation by new investors. The market approach attempts to value an asset or security by examining observable market values for similar assets or securities. As one application of the market approach, a valuation specialist may utilize observable valuations for transactions in the entity’s securities and use the back-solve method to solve for the implied equity value using the OPM. The basis for application of this method is transactions in equity securities of the enterprise with unrelated investors as an observable measure of fair value. The use of this valuation approach was based on the observed prices in the Series Seed preferred stock financing (the “Series Seed Financing”) and the Series A Financing. Both of these financings included material participation by new investors and are considered to be “arms-length” transactions. The third-party valuation firm and Archer utilized a hybrid of the OPM back-solve approach on the valuation dates of December 3, 2019 and September 17, 2020. Under this hybrid OPM, the implied equity value was determined using two exit scenarios for Archer: an early and late stage exit event. Each exit scenario is assigned a probability based on the third-party appraiser’s review of relevant studies and discussions with the entity’s management team. Under each scenario, the Black-Scholes OPM was used to allocate value to the various share classes such that the probability weighted share value of the Series Seed preferred stock or Series A preferred stock, as applicable, equaled the respective original issue price of $0.33 per share and $1.20 per share, the latter of which was rounded in the report from $1.2046 per share. The OPM treats securities, including debt and common and preferred stock, as a series of call options on the enterprise’s value, with exercise prices based on the securities’ respective liquidation preferences and conversion values. Accordingly, the common and preferred stock is considered to be a call option with a claim on the enterprise at an exercise price equal to the remaining value immediately after the liquidation preferences are fulfilled, and considering the relevant rights of the preferred stock (e.g. participation) as well as the potential dilution from other outstanding securities such as options and warrants. The OPM considers five key inputs: the total consideration of the most recent transaction, the rights and preferences of the shareholders, time-to-liquidity, the risk-free interest rate, and volatility. The hybrid OPM was used to both determine the estimated value of the enterprise as a whole and to allocate the value to the outstanding securities. Probability Weighted Expected Return Method The PWERM values each class of equity based on an analysis of the range of potential future enterprise values of Archer and the manner in which those values would accrue to the owners of the different classes of equity. This method involves estimating the overall value of the subject company under various liquidity event scenarios and allocating the value to the various share classes based on their respective claim on the proceeds as of the date of each event. These different scenarios typically include an IPO, a business combination, or a liquidation of the business, each resulting in a different value. For each scenario, the future value of each share class is calculated and discounted to a present value. The results of each scenario are then probability weighted in order to arrive at an estimate of fair value for each share class as of a current date. The PWERM is typically utilized when potential exit events, such as an IPO or a business combination, can be well defined. As such, the PWERM can give more weight to the likely exit scenarios, as opposed to the normative distribution of outcomes in the OPM. For the valuation performed as of January 12, 2021, Archer equity value was allocated using a hybrid method incorporating both the OPM and the PWERM. The hybrid method applied the PWERM utilizing the probability of completing the Business Combination and the OPM was utilized in the remaining private scenario. Archer began using the hybrid model because it better assessed the near-term potential business combination scenario, while also factoring in the inherent uncertainty in outcomes if Archer was to remain private. In determining the estimated fair value of the Common Stock on the date of grant, the Archer Board also considered that the Common Stock is not freely tradeable in the public markets. The estimated fair value of the Common Stock at each grant date therefore reflects a discount for lack of marketability (“DLOM”) partially based on the anticipated likelihood and timing of a future liquidity event. Since January 2020, the Archer Board has granted the following equity awards, with the share numbers and per share exercise prices and fair values: Reassessed Fair Market Value Per Share represents a retrospective revaluation solely for financial reporting purposes as further discussed below. In the absence of a public trading market, the Archer Board, with input from management, exercised significant judgment and considered numerous objective and subjective factors to determine the fair value of the Common Stock as of the date of each option grant, including the factors discussed on pages 194 and 195 of the Registration Statement. In November 2019, Archer entered into a preferred stock purchase agreement (the “Series Seed Preferred Stock Purchase Agreement”) with existing and new investors to raise up to $6.0 million in two separate tranches. In November 2019, Archer issued and sold an aggregate of 3,042,000 shares of its Series Seed preferred stock pursuant to the Series Seed Preferred Stock Purchase Agreement at a purchase price of $0.3300 per share for an aggregate purchase price of $1.0 million (the “Series Seed First Tranche Investment”). In December 2019, Archer issued and sold an aggregate of 15,151,515 shares of its Series Seed preferred stock pursuant to the Series Seed Preferred Stock Purchase Agreement at a purchase price of $0.3300 per share for an aggregate purchase price of $5.0 million (the “Series Seed Second Tranche Investment”). The Series Seed Financing was considered to be an arms-length transaction due to the fact that the pricing was negotiated fairly and no strategic, non-financial elements were incorporated into the pricing terms. Investment, Archer, with the assistance of a third-party valuation firm, performed a valuation of the Common Stock as of December 3, 2019 on a minority, non-marketable basis using the hybrid OPM back-solve method, solving for a total stockholders’ equity value under two scenarios: an early exit and late exit event, with a 75% and 25% probability rate, respectively. Given the recency of the Series Seed Second Tranche Investment to the valuation date, the valuation firm determined that the marketable value per share of the Series Seed preferred stock was equal to its original issue price of $0.33 per share. The total equity value implied by the Series Seed Financing was then applied in the context of an option pricing model to determine the value of each class of Archer’s shares. The early exit scenario analysis assumed: (i) a term of approximately one year as the timing to a potential liquidity event based on the risk associated with expanding Archer’s business; (ii) a risk-free rate of 1.57%, based on the rate of U.S. Treasury securities, with the same term as the applicable time to liquidity, as of the valuation date; (iii) an equity volatility rate of 15% based on an analysis of volatility rate of certain comparable public companies and factors specific to Archer; and (iv) a 75% probability rate with a liquidation value equal to Archer’s invested capital. (i) a term of approximately five years as the timing to a potential liquidity event based on discussions with Archer’s management regarding potential timing of milestone achievements; (iii) an equity volatility rate of 70% based (iv) a 25% probability rate with a liquidation Based on the above, the analysis resulted in equity values for the early and late exit scenarios of approximately $6.0 million and $21.1 million, respectively, on a minority marketable basis. Collectively, when backsolved together these result in a probability-weighted total implied equity value of approximately $9.8 million. The valuation then considered the senior rights, preferences and privileges of the holders of Archer’s preferred stock over the holders of the Common Stock, including the right to receive dividends prior to any dividends declared or paid on any shares of the Common Stock and liquidation payments in preference to holders of Common Stock in the event of a liquidation. A DLOM of 49%, was then applied to the Common Stock resulting in a fair value of $0.04 per share (the “December 2019 Valuation”). In February 2020, the Archer Board granted options to purchase 3,244,245 shares of Common Stock with an exercise price of $0.04 per share. In determining the fair value of the Common Stock for the February 2020 grants, the Board considered the December 2019 Valuation, relevant business conditions and the absence of any changes that would materially impact Archer’s equity value since the time of the December 2019 Valuation. In April 2020, the Archer Board granted options to purchase 469,960 shares of Common Stock with an exercise price of $0.04 per share. In determining the fair value of the Common Stock for the April 2020 grants, the Board considered the December 2019 Valuation, relevant business conditions and the absence of any changes that would materially impact Archer’s equity value since the time of the December 2019 Valuation. On September 17, 2020, Archer issued and sold an aggregate of 1,660,302 shares of its Series A preferred stock pursuant to the Series A Stock Purchase Agreement at a purchase price of $1.2046 per share for an aggregate purchase price of $2.0 million (the “Series A Tenth Tranche Investment”). Following the Series A Tenth Tranche Investment, Archer, with the assistance of a third-party valuation firm, performed a valuation of the Common Stock as of September 17, 2020, on a minority, non-marketable basis using the hybrid OPM. Given the recency of the Series Seed Second Tranche Investment to the valuation date, the valuation firm determined that the marketable value per share of the Series A preferred stock was equal to $1.20. The total equity value implied by the Series A Financing was then applied in the context of an option pricing model to determine the value of each class of Archer’s shares. (iii) an equity volatility rate of 60% based equity values for the early and late exit scenarios of approximately $57.2 million and $133.5 million, respectively, on a minority marketable basis. Collectively, when backsolved together these result in a probability-weighted total implied equity value of approximately $76.3 million. The valuation then considered the senior rights, preferences and privileges of the holders of Archer’s preferred stock over the holders of the Common Stock, including the right to receive dividends prior to any dividends declared or paid on any shares of the Common Stock and liquidation payments in preference to holders of Common Stock in the event of a liquidation. A DLOM of 50%, was then applied to the Common Stock resulting in a fair value of $0.15 per share (the “September 2020 Valuation”). In November 2020, the Archer Board granted options to purchase 9,028,222 shares of Common Stock with an exercise price of $0.15 per share. In determining the fair value of the Common Stock for the November 2020 grants, the Board considered the September 2020 Valuation, relevant business conditions and the absence of any changes that would materially impact Archer’s equity value since the time of the September 2020 Valuation. On January 7, 2021, the Archer Board granted options to purchase 1,269,289 shares of Common Stock with an exercise price of $0.15 per share. However, with the benefit of hindsight as to how discussions with Atlas Crest regarding a proposed business combination and with a significant new business partner resolved, Archer has determined that it is appropriate to reassess the fair value of the January 7, 2021 option grants for accounting and financial reporting purposes as $13.78 per share, consistent with the valuation performed as of January 12, 2021 (as discussed below). As the aforementioned activities did not commence until December 2020, Archer determined that it is appropriate to have relied on the September 2020 Valuation to determine the fair market value of the Common Stock for the awards granted on November 3, 2020. 2021, Archer, with the assistance of a third-party valuation firm, performed a valuation of the Common Stock as of January 12, 2021 on a minority, non-marketable basis using a hybrid of the OPM and PWERM which considered two different future-event scenarios: Business Combination in May 2021: Archer estimated a 75% probability associated with a business combination in the May 2021 timeframe. The equity value of Archer in a liquidity event at this date was estimated to be approximately $2.5 billion based on: (i) initial discussions with Atlas Crest, which began on December 31, 2020, regarding a potential business combination; (ii) the non-binding term sheet from Atlas Crest, dated January 17, 2021, for the business combination, pursuant to which Archer’s equity was valued at approximately $2.7 billion, 1.2x based on 2026 estimated revenue and 4.2x based on 2026 estimated EBITDA; (iii) discussions with Archer management; and (iv) consideration of recent transactions of companies in a similar stage of development with special purpose acquisition companies. Archer estimated a 25% probability of remaining private for approximately three years. The application of the OPM was determined to be an appropriate methodology under this scenario. As discussed above, a stay private scenario value was estimated using the income approach (discounted cash flow method) and market approach (guideline public company method) from which derived value was allocated using the Both scenarios factored in the collaboration agreements that Archer entered into with United Airlines on January 29, 2021 and Stellantis on November 6, 2020, as well as the equity value of $2.7 billion per the business combination agreement. Due to these factors, Archer’s management adapted its projections of its results of operations, capital expenditures, and working capital, which resulted in the increase in the overall business enterprise value. The probabilities assigned to each scenario above were based on Archer’s assessment of its aircraft development pipeline and market conditions. A higher weighting was assigned to the “business combination” scenario given Archer’s entry into a non-binding letter of intent with Atlas Crest; however, due the need to raise commitments for significant funds in the private market prior to the execution of the business combination agreement a weighting of 75% was assigned. For each scenario, Archer then applied a DLOM as noted in the table above, in each case determined based on a put option analysis, which considered the timing of each scenario. The January 12, 2021 valuation resulted in an estimated fair value of the Common Stock of $13.78 per share. The implied fair value of the shares of Common Stock as determined by the exchange ratio described in the business combination agreement is $17.30 per share, based on various assumptions described in the Registration Statement. There are several factors that Archer believes contribute to the differences in fair value of Archer options granted prior to December 31, 2020, relative to the implied fair value of Common Stock of $17.30 per share with respect to the proposed business combination. These factors include: ● At the time of such grants, there remained significant global economic uncertainty particularly in relation to the ongoing COVID-19 pandemic. By the time discussions with Atlas Crest had commenced in December 2020, the approval of a vaccine was on the horizon, and by the time the business combination agreement was executed in February 2021, lockdowns had been unwound in many countries and focus had begun to shift towards facilitating economic recovery. December 31, 2020, Archer and Atlas commenced discussions regarding a potential business combination. January 17, 2021, Archer and Atlas entered into a non-binding term sheet. January 29, 2021, Archer and United Airlines entered into an aircraft purchase agreement related to the purchase of an Archer aircraft and a collaboration agreement related to the development of such aircraft. Archer experienced significant growth during the first quarter of 2021, particularly in areas relevant to Archer’s business and outlook, such as work force, facility footprint and prototype design and integration. February 10, 2021, Archer and Atlas executed a binding business combination agreement. ● The equity markets continue to experience significant demand due to the historically low interest rate environment as a result of actions taken by the Federal Reserve. In this interest rate environment, investors are looking for yield which they believe can be found in quality investments in the equity markets.
Please balance the disclosure in your summary by prominently disclosing the early development stage, history of losses and expectation of future losses for Archer. Also please briefly discuss the going concern language in Archer's auditor’s report, as disclosed on page 30.
See the reply above.
Please revise the post-business combination structure diagram to disclose the respective percentage ownership and voting power of the four investor groups depicted therein.
See the reply above.
We note your disclosure related to adjustments (i) and (dd). Please revise your disclosure to explain why the amounts shown for these adjustments differ given that both adjustments reflect estimated Archer Founder Grant restricted stock unit compensation expense.
See the reply above.
Please provide us with additional detail explaining the basis for the grant date fair value of the common stock underlying stock options issued during 2020 and, if applicable, 2021. As part of your response, include detail regarding options issued by date of grant and explain any factors that resulted in changes in valuation.Rest of the question
In addition, explain the reasons for differences between the valuations of your common stock at the grant date for options you issued and the valuation determined as part of your proposed business combination transaction. Archer Aviation Inc.
See the reply above.
We note that when determining the fair value of your common stock, you utilized valuations prepared by an independent third party. While you are not required to make reference to this third party, when you do you should also disclose the name of this expert and include the consent of the expert as an exhibit. Please revise accordingly.Rest of the question
For additional guidance, refer to question 233.02 of the Compliance and Disclosure Interpretations regarding Securities Act Rules.
See the reply above.
We note that you entered into partial recourse promissory note arrangements with Archer’s founders on November 21, 2020 which provided each of them with a partial recourse loan as consideration for the issuance of stock, which proceeds were used for the exercise of shares of common stock pursuant to option agreements issued to the founders on November 3, 2020.Rest of the question
Revise your disclosure to more clearly explain these transactions and provide us with an explanation of your accounting treatment with citations to the relevant authoritative guidance.
See the reply above.
Please file the following as exhibits to the registration statement: • the Registration Rights Agreement; and • a legal opinion regarding the legality of the securities being registered. See Item 601(b)(5)(i) of Regulation S-K.
See the reply above.
Please tell us how you considered filing the various agreements you discuss under "Material Agreements" on pages 184 - 185 as exhibits to the registration statement. Please refer to Item 601(b)(10) of Regulation S-K.
See the reply above.
We note that you have incorporated by reference certain documents into the proxy statement/prospectus, including the Letter Agreement and form of Subscription Agreement, as referenced on pages 8 and 9, respectively. Please provide your analysis as to how you determined your eligibility for incorporation by reference.
The Company acknowledges the Staff’s comment and has revised the disclosure on pages 8, 9, 88 and 89 of the Amendment to reference the relevant exhibit to the Amendment or Annex to the proxy statement/prospectus which forms a part of the Amendment.Read in the reply
The internally prepared forecasts included in your filing present information for each of the years in the six-year period ending December 31, 2030. Considering your statement that, by its nature, this information becomes less reliable with each successive year, revise to explain how this period of time was selected.
The Company acknowledges the Staff’s comment and respectfully advises the Staff that the six-year period beginning in 2024 was selected because of the assumption that certification of Archer’s aircraft would occur by the end of 2024. Furthermore, Archer’s management chose to present a six-year period following such certification because, in the view of Archer’s management, such a period would allow a reasonable amount of time for Archer’s production and business operations to ramp up to meet production and sales forecasts.Read in the reply
The statement regarding reliability of the information primarilyRest of the answer
focuses on the difficulty in estimating accurate financial results in those distant future years, as the number of events that could change the outcome of those results increases. However, we believe the presentation of this six-year period was helpful because, assuming the certification of Archer’s aircraft at the end of 2024, the six-year period is sufficient time to show how the Archer business model is designed to work, including production and sales growth and maturation, following certification and commercialization activities. Accordingly, we have revised the disclosure on page
101 of the Amendment.
Disclosure on page 99 states that the prospective financial information included in your filing reflects the best currently available estimates and judgments, but disclosure on page 100 states that this information does not take into account any circumstances or events occurring after the date it was prepared.Rest of the question
Please revise to clarify the timeliness of the information provided and whether there were any notable changes after the time when it was prepared.
The Company acknowledges the Staff’s comment and respectfully advises the Staff that no significant circumstances or events have taken place since the preparation of the financial forecast, other than the litigation matter with Wisk that has been disclosed in the Amendment. The litigation and investigation is at an early stage, and while Archer believes this claim is without merit Archer is not able to reasonably predict or estimate the potential costs of this matter at this time.Read in the replyRest of the answer
Archer does not believe that this matter would have any material effect on these prior estimates and judgements after the time when they were prepared. Accordingly, we have revised the disclosure on page 101-102 of the Amendment to add additional clarity on this point.
We note your statement that the financial projections reflect numerous estimates and assumptions with respect to various conditions and future events, as well as matters specific to Archer’s business. Expand your disclosure to more fully describe the process through which these projections were prepared, including additional information regarding the underlying material assumptions made (e.g., the nature of theRest of the question
assumed market for Archer’s electric aircraft, the basis for growth rates and how they were deemed to be reasonable, the correlation between forecasted revenues, costs and expenses, capital expenditures, and aircraft production, etc.).
The Company acknowledges the Staff’s comment and has revised the disclosure on page 101-103 of the Amendment.Read in the reply
On pages 99 - 100, please remove or modify the statement cautioning investors not to rely on projections included in the proxy statement/prospectus.
The Company acknowledges the Staff’s comment and has revised the disclosure on pages 102 of the Amendment.Read in the reply
EBITDA is defined on page 101 as revenue for the period presented less payments for direct and indirect operating costs, cost of goods sold, and general and administrative expenses. Please revise as this definition appears to be inconsistent with the definition of EBITDA per Item 10(e)(1)(ii)(A) of Regulation S-K.Rest of the question
As part of your revised disclosure, clarify whether forecasted EBITDA presented in your filing includes research and development expenses. In addition, note that your definition of free cash flow appears to be inconsistent with the definition per question 102.07 of the Compliance & Disclosure Interpretations regarding Non-GAAP Financial Measures.
The Company acknowledges the Staff’s comment and respectfully advises the Staff that (i) it has clarified the definition of EBITDA on page 104 of the Amendment and (ii) the assumptions and underlying estimates remain the same. In addition, we have revised the disclosure on page 104 of the Amendment to remove the reference to the Non-GAAP measure of free cash flow.Read in the reply
We note the disclosure on page 104 that the Atlas Board’s financial advisor, Duff & Phelps, has furnished its fairness opinion "solely for the use and benefit of the Atlas Board in connection with its consideration of the Business Combination" and this opinion "was not intended to, and does not, confer any rights or remedies upon any other person, and is not intended to be used, and may not be used, by any otherRest of the question
person or for any other purpose, without Duff & Phelps’ express consent." Please also refer to similar language contained in the fairness opinion. This disclosure suggests that shareholders may not consider or rely on the information in the opinion. Because it is inconsistent with the disclosures relating to the opinion, the limitation should be deleted. Alternatively, disclose the basis for Duff & Phelps’ belief that shareholders cannot rely on the opinion to support any claims against Duff & Phelps arising under applicable state law (e.g., the inclusion of an express disclaimer in Duff & Phelps’ engagement letter with the company). Describe any applicable state-law authority regarding the availability of such a potential defense. In the absence of applicable state-law authority, disclose that the availability of such a defense will be resolved by a court of competent jurisdiction. Also disclose that resolution of the question of the availability of such a defense will have no effect on the rights and responsibilities of the board of directors under applicable state law. Further disclose that the availability of such a state-law defense to Duff & Phelps would have no effect on the rights and responsibilities of either Duff & Phelps or the board of directors under the federal securities laws.
The Company acknowledges the Staff’s comment and has revised the disclosure relating to the Duff & Phelps’ opinion on page 107 of the Amendment.Read in the reply
We note the revisions made in response to prior comment 4, but the reasons for differences in pro forma adjustment amounts in (I) and (DD) are still not apparent. Please revise your disclosure further to explain why the dollar amounts for these adjustments differ.
The Company acknowledges the Staff’s comment and has revised the disclosure on page 153-154 of the Amendment.Read in the reply
Please revise to include disclosure on the litigation related to the Business Combination and to cross-reference the related risk factor on page 48 or advise.
The Company acknowledges the Staff’s comment and has revised the disclosure on page 162 of the Amendment.Read in the reply
Please revise to include a cross-reference to the related risk factor disclosure on the recent Wisk litigation and government investigation. Archer Aviation Inc.
The Company acknowledges the Staff’s comment and has revised the disclosure on page 201 of the Amendment.Read in the reply
Archer Aviation Inc.
We note that, in connection with entering into a collaboration and purchase agreement with United Airlines in January 2021, Archer issued warrants to purchase shares of its common stock which vest upon the satisfaction of certain milestones.Rest of the question
Tell us how you concluded that a portion of the warrants issued should be accounted for pursuant to FASB ASC 718 while the remainder should be accounted for pursuant to FASB ASC 606 and FASB ASC 718. In addition, explain your basis for the recognition patterns described in your disclosure. As part of your response, tell us how the identification of United Airlines as a customer was considered in determining the appropriate accounting treatment. Also tell us whether the guidance per ASU 2019-08 has been adopted.
The Company acknowledges the Staff’s comment and has included a discussion below to both clarify and support Archer's basis of accounting for Archer's existing warrants to purchase common stock issued to United Airlines (“United”) as part of the collaboration, purchase, and warrant agreements (“United Agreements”).Read in the replyRest of the answer
In addition, the Company has drafted revised disclosures on pages F-78, F-81, F-89 and F-90 of the Amendment to more clearly describe the transactions and the related accounting for the warrants issued to United.
On January 29, 2021, Archer entered into the United Agreements with United. Under the terms of the purchase agreement, United has committed to purchase 200 Archer aircraft, with an option to purchase an additional 100 aircraft, provided that a new type of aircraft, which meets United’s requirements for urban environments, is developed and approved for commercial aviation. Additionally, the parties agreed to form a commercial relationship to advance the business of operating aircraft in urban environments for commercial purposes. To incentivize United to enter into the purchase agreement, Archer issued 14,645,614 warrants to United to purchase shares of its common stock at an exercise price of $0.01 per share.
Pursuant to the warrant agreement, the warrants vest upon the completion of four contingent milestone events:
1. 5,858,246 shares vest immediately upon execution of the warrant agreement (“Milestone One”).
2. 2,929,123 shares vest upon completion of a financing transaction in which United is a participant (“Milestone Two”).
3. 1,464,561 shares vest upon approval of the aircraft’s final certification by the Federal Aviation Administration (“FAA”) (“Milestone
Three”).
4. 4,393,684 shares vest upon acceptance of delivery and final purchase by United of each aircraft (“Milestone Four”).
Archer first considered whether the United Agreements should be accounted for under FASB ASC 808. In considering the criteria in FASB ASC 808-10-15 and the FASB ASC Master
Glossary, Archer determined the United Agreements did not represent a collaboration pursuant to such criteria because United is not an active participant in developing the aircraft. Specifically, United is not providing any technology, is not incurring any costs in the development of the aircraft or bearing any significant risks and rewards and has no ownership rights in any joint intellectual property
(the “IP”) developed.
Archer next assessed whether the United Agreements should be accounted for under FASB ASC 606. In considering the guidance in FASB ASC 606-10-15-3, Archer concluded the purchase agreement qualifies as a contract with a customer. As a result of signing the purchase agreement, United became a customer with the intention of obtaining output from Archer’s ordinary operating activities, which was a newly designed type of aircraft authorized for commercial aviation. United has not contracted to share in the risks and benefits of developing the aircraft and will not be involved in the development and production of the aircraft or its underlying IP. As a result, Archer determined that both the United
Agreements fell within the scope of FASB ASC 606. Therefore, Archer’s accounting assessment was based on the guidance in ASC 606 as amended by ASU 2019-08. Archer adopted ASU 2019-08 as of January 1, 2021 and included such disclosure within Note 3 of the Condensed
Financial Statements as of and for the three months ended March 31, 2021.
Archer determined that the warrants issued, in their entirety, to United should be accounted for under FASB ASC 606 as consideration payable to a customer as described in
ASC 606-10-32-25(c). Specifically, the warrants issued to United to purchase common stock of Archer were issued in conjunction with a revenue contract. Archer recognizes that this is a point of clarity with respect to the Staff’s comments on the accounting for warrants associated with the four milestones. Accordingly, Archer has revised the disclosure on pages F-89 and F-90 of the Amendment. Refer to the discussion below with respect to Archer’s analysis that further discusses why it believes that warrants issued, in their entirety, are accounted for under ASC 606.
Archer considered the guidance in ASC 606-10-32-25A in determining both the measurement and recognition of the consideration to be paid to United under the four milestones.
With respect to measurement, Archer will measure all of the warrants at their grant date fair value, as of January 29, 2021, consistent with the measurement guidance in ASC 718. With respect to classification, Archer considered the criteria in ASC 718, which included consideration of ASC 480, to determine that the warrant should be classified as equity.
ASC 606-10-32-25 states that:
“Consideration payable to a customer also includes equity instruments (liability or equity classified) granted in conjunction with selling goods or services
(for example, shares, share options, or other equity instruments). An entity shall account for consideration payable to a customer as a reduction of the transaction price and, therefore, of revenue unless the payment to the customer is in exchange for a distinct good or service that the customer transfers to the entity.”
ASC 606-10-32-26 further states that:
“If the amount of consideration payable to the customer exceeds the fair value of the distinct good or service that the entity receives from the customer, then the entity shall account for such an excess as a reduction of the transaction price. If the entity cannot reasonably estimate the fair value of the good or service received from the customer, it shall account for all of the consideration payable to the customer as a reduction of the transaction price.”
As further discussed below, we have clarified our view that Archer is not receiving distinct goods or services from United that could be reasonably estimated, and therefore view the value of the warrants, when recognized, to be a reduction of the transaction price with United for accounting purposes.
Next, Archer considered the pattern of recognition and presentation of the value of the warrants. ASC 606-10-32-27 states, “Accordingly, if consideration payable to a customer is accounted for as a reduction of the transaction price, an entity shall recognize the reduction of revenue when (or as) the later of either of the following events occurs:
i. The entity recognizes revenue for the transfer of the related goods or services to the customer.
ii. The entity pays or promises to pay the consideration (even if the payment is conditional on a future event). That promise might be implied by the entity’s customary business practices.”
Archer accounted for Milestone
One (issuance of Warrant Agreement) under ASC 606. Archer does not believe that the consideration payable for Milestone One was provided in exchange for a distinct good or service. Rather, the consideration was to induce United to commit to a contingent purchase agreement for an aircraft from Archer, which also provides valuable credibility to Archer to have such an anchor customer. As such, Archer believes that ASC 606 indicates that such consideration payable to the customer should be accounted for as a reduction to the transaction price.
Archer also considered the guidance FASB Revenue Recognition Implementation Guide, Question 43: How should an entity account for upfront payments to a customer?, from the Transition Resource Group (“TRG #43”) in considering how to account for the Milestone One warrants. Based on the interpretive guidance of ASC 606 and TRG #43, Archer believed that an asset (representing a prepaid discount) would conceptually be recognized upon the vesting date of these warrants based upon the grant date fair value, which would be amortized as a discount to the sales price when the related aircraft are sold in the future. However, consistent with TRG #43 Archer should assess that asset for recoverability and impairment.
In assessing the Milestone One asset for impairment, Archer concluded that the asset was not probable of recovery at that time and should be written off and recorded as an expense instead. The aircraft to be sold to United was conceptual in January 2021 when the agreement was executed. For the purposes of this analysis, there is no assurance (i) that Archer can develop a suitable commercially feasible design meeting United’s requirements under the purchase agreement for urban environment flight and (ii) that such an aircraft can obtain regulatory approval for commercial use by United in its target market areas. As such, for purposes of this analysis, there is uncertainty regarding the generation of revenue from the future sale of such aircraft. Archer was willing to grant the Milestone One warrants for the enhanced credibility such relationship provides to Archer. Specifically,
· The expectation of
Archer is that the final type certificate (Milestone Three) would not be approved until Q4 of 2024; and
· Archer’s ability to generate sufficient sales of the aircraft to support the recoverability of the asset is fully dependent on achieving Milestone Three.
Based on both the guidance referenced above as well as the current facts and circumstances of Archer, we determined it reasonable to record the grant date fair value of Milestone
One as an expense in the statement of operations and comprehensive loss upon vesting. While Archer believed that the payment conceptually could be recorded as an asset, for purposes of this analysis, the likelihood of generating future revenues with United was not deemed probable as of the reporting period. Thus, Archer recorded the grant date fair value of Milestone One to research and development expense as opposed to a prepaid discount asset.
Archer did consider whether this charge should be classified as contra-revenue or expense. We note that ASC 606-10-25-25 refers to recording payments to customers as a reduction of revenue, and TRG #43 was silent on this point. However, Archer believes that in its particular facts and circumstances
– where there is no revenue at all and it is unlikely that there will be revenue for several years, presentation of such amounts as “negative revenue” would not best represent the economics of the arrangement and would be difficult for investors to understand.
It is not a payment associated with a previous revenue contract, and it is not part of a broader economic arrangement involving a pool of other customers. Given Archer’s current stage of development in the research and development phase, Archer concluded that the most appropriate classification was as an expense.
Two (Completion of a financing transaction where United is a participant) under ASC 606. Archer does not believe that any portion of this milestone represents a cost of financing due to the vesting requirement of United to participate in a financing transaction. Specifically, no participants in the financing transaction were issued additional awards, or a warrant for additional shares for participating in the financing. In other words, as United participated in the financing on the same terms as other unrelated investors who did not receive warrants, Archer does not believe that any of the warrants in Milestone Two represent the fair value of costs incurred as part of the financing and therefore the warrants were not issued to United in their capacity as an investor. Rather, Archer respectfully submits that the warrants were issued to United solely due to its participation in the United Agreements, coupled with the commercial relationship.
With respect to the recognition pattern and presentation of the warrants associated with Milestone Two, Archer believes that both the guidance and unique facts and circumstances discussed for Milestone One will apply. As this milestone is not yet vested, Archer considered the probability of the performance condition. Consistent with FASB ASC 805-20-55-50 through FASB ASC 805-20-55-51 by analogy, a company typically cannot conclude it is probable that a liquidity event, such as a change in control of the company, will occur until the date of consummation of the liquidity event because such an event is outside the company’s control and generally is not considered to be probable until the event occurs. This suggests that the expense for these warrants should not be recognized until the consummation of the Business Combination.
Upon vesting, Archer will record the grant date fair value of the Milestone Two warrants to research and development expense on the statement of operations and comprehensive loss because, at the consummation of the financing, for purposes of this analysis, the delivery of a commercially viable aircraft meeting United’s requirements is uncertain. Thus, the recoverability of a potential prepaid discount asset is still expected to be highly in doubt.
Three (Approval of the aircraft’s final certification by the FAA) under ASC 606. As discussed above, Archer is targeting this certification to occur in Q4 of 2024. Archer recognizes that if it can achieve certification by the FAA for its aircraft, the probability of generating future revenues associated with the committed United purchase agreement becomes probable. Therefore, when Archer believes it is probable that Milestone Three will be achieved, it will begin capitalizing the grant date fair value of the warrants associated with Milestone
Three as an asset through the vesting date consistent with guidance at ASC 606 and TRG 43. Archer will subsequently amortize the asset as a reduction to revenue as it sells the aircraft to United.
Four (Acceptance of delivery and final purchase by United of each aircraft) under ASC 606. Under the warrant agreement, 1/200th of the
4,393,684 unvested warrants shall become vested and exercisable upon the acceptance of delivery and final purchase by United of each aircraft.
The purchase agreement also provides United with an option to buy an additional 100 aircraft; however, no shares from the warrant agreement are attributable to that option. Consistent with the guidance in ASC 606, Archer will record the cost (measured at the original grant date in accordance with ASC 718) associated with the vesting of each portion of warrants within this milestone as revenue is recognized for each sale of the aircraft as a reduction of the transaction price.
We note from your Exhibit Index that the consent of Duff & Phelps filed as Exhibit 23.3 was included as Annex H to the proxy statement/prospectus, but we were unable to locate such consent. Please revise or advise.
The Company acknowledges the Staff’s comment and has filed the consent of Duff & Phelps as Exhibit 23.3 to the revised Amendment.Read in the reply
We are unable to locate the Registration Rights Agreement, which your response to comment 8 indicates has been filed as Annex I to the revised registration statement. In this regard, it appears that a copy of the ESPP is included as Annex I. Please revise or advise.
The Company acknowledges the Staff’s comment and has filed the ESPP as Annex G and has filed the Registration Rights Agreement asRead in the reply
Annex I to the revised Amendment.
We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions related to this letter, please contact the undersigned (by telephone at (212) 446-4660 or by email at [email protected]) or Tamar Donikyan (by telephone at (212) 909-3421 or by email at [email protected]).
We note that the revised disclosure provided with regard to material estimates and assumptions underlying forecasted revenues. Expand this disclosure further to address the factors or contingencies that would affect forecasted revenue growth ultimately materializing.
In response to the Staff’s comment, we intend to revise the disclosure as reflected on page 103 of Annex B to further address the factors or contingencies affecting forecasted revenue growth.Read in the reply
You state that material estimates and assumptions underlying projections of demand volumes for Archer UAM were developed working with Archer's data simulation team that used third-party data available to measure travel patterns in various markets to model potential demand.Rest of the question
Revise to provide additional disclosure regarding the markets used to model demand and state whether those are markets where Archer expects to operate during the projection period. In addition, explain in greater detail how the assumed price per customer mile and average trip distance were determined (including whether other assumptions were considered that could create variability in the projected amounts). Also, indicate whether the assumed price per customer mile was held constant or was adjusted.
In response to the Staff’s comment, we intend to revise the disclosure as reflected on page 103 of Annex B to further explain the assumptions underlying the projections.Read in the reply
We note your response to prior comment 4 and reissue it in part. It does not appear that the revised disclosure includes information regarding the correlation between forecasted revenues, costs and expenses, capital expenditures, and aircraft production. Please provide this type of disclosure. Archer Aviation Inc.
In response to the Staff’s comment, we intend to revise the disclosure as reflected on pages 103 and 104 of Annex B to further expand the disclosure.Read in the reply
Archer Aviation Inc.
We note your response to prior comment 11. Please revise your disclosure regarding the first milestone to include language similar to that provided in your response related to your accounting for the warrants issued to United, including that the warrants were not issued in exchange for a distinct good or service.Rest of the question
In addition, clarify the statement on page F-89 that United and Archer "have agreed to collaborate to advance the business of operating aircraft in urban environments for commercial purposes" as United has not contracted to share in the risks and benefits of developing the aircraft and will not be involved in development or production.
In response to the Staff’s comment, we intend to revise the disclosure as reflected on pages F-90 and F-91 ofRead in the reply
Annex B. Attached here as Annex B is the form of warrant agreement with United Airlines, which will be filed as an exhibit to the Registration Statement.
As it relates to the collaboration and purchase agreement between Archer and United, we note from your response to prior comment 11 that United is not an active participant in developing the aircraft. Additionally, your response states that United is not providing any technology and is not incurring any costs in the development of the aircraft.Rest of the question
Based on this description, tell us how your classification of the Milestone One warrant costs (i.e., vesting upon execution of the warrant agreement) is consistent with the definition of research and development per FASB ASC 730-10-20.
The Company acknowledges the Staff’s comment and has provided a discussion below to clarify Archer's classification of theRead in the reply
Milestone One warrant costs. In addition, in response to the Staff’s comment and our discussion with the Staff, we intend to revise the disclosure as reflected on pages 26, 151, 206 through 209, F-71, F-73, F-76, F-78 and F-91 of Annex B.
Archer recognizes that United
Airlines (“United”) is not an active participant in developing the aircraft.Rest of the answer
Specifically, United is not providing any technology, is not incurring any costs in the development of the aircraft or bearing any significant risks and rewards and has no ownership rights in any joint intellectual property (the “IP”) developed. Archer classified the recognition of the warrant costs associated with Milestone One as research and development because it felt that it best depicted both the nature of the arrangement as well as its current stage of development with respect to the requested aircraft. Pursuant to the arrangement between the companies, United is cooperating with Archer relating to Archer’s FAA certification, airline flight connections, pilot and maintenance crew training and support for Archer’s go-to-market strategy for city launches and airport connections.
However, in consideration of the Staff’s comment and further analysis of ASC 730-10-20, as well as the different nature of the cost of the warrants as compared to the Company’s other operations, Archer believes that the recognition of the warrant costs associated with Milestone One should instead be classified as an other warrant expense, which would be presented as a separate financial statement line item within operating expense of its statement of operations and comprehensive loss. While Archer maintains that its current stage of development is within the research and development stage, it acknowledges that the nature and intent of issuing the warrants associated with Milestone One was independent of such activities and the related costs of the Milestone One warrants are not consistent with research and development costs as defined per ASC 730-10-20.
Milestone Two, the second contingent milestone event of the warrant agreement between Archer and United, relates to the completion of a financing transaction where United is a participant. Tell us more about the conclusion that the warrants were not issued to United in their capacity as an investor (i.e., how it was determined that United would have agreed to participate in a financing transaction on the same termsRest of the question
as those described in your filing if not for the issuance of warrants).
The Company acknowledges the Staff’s comment and has provided a discussion below to both clarify and support Archer’s determination that we do not believe that the warrants reflect an element of the financing transaction. In addition, in response to the Staff’s comment and our discussion with the Staff, we intend to revise the disclosure as reflected on page F-91 of Annex B. In addition, attached hereto as Annex A is the warrant agreement with United Airlines.Read in the reply
Archer initiated conversations with United in regard to them becoming an anchor customer in early December 2020.Rest of the answer
The discussions centered around
United placing a substantial order for a new type of aircraft, if one could be designed to meet United’s specifications and receive regulatory approval for commercial flight, and providing advice that would accelerate the time to market in exchange for warrants to purchase a 10% ownership stake in Archer. Archer and United entered into a term sheet on January 13, 2021, which set forth the material terms of their customer relationship. That term sheet also set forth the warrant vesting conditions that were eventually incorporated into the definitive United Agreements. On January 29, 2021, Archer and United entered into the Aircraft Purchase Agreement, Collaboration Agreement and Warrant Agreement (“United Agreements”).
The objective of the warrant vesting conditions was to align incentives between the two companies to their respective goals of the relationship. Archer’s objective was to establish a relationship with an anchor customer who could expedite its efforts to design, certify, manufacture and sell a new eVTOL aircraft and provide credibility in the marketplace to raise significant capital in a future financing transaction. A successful financing transaction was needed by Archer to complete its objective. United’s goal was to partner with an eVTOL company as part of its broader effort to invest in emerging technologies that reduce carbon emissions from air travel. Therefore, the parties agreed to tie one of the vesting milestones to the successful completion of a future financing transaction.
For accounting purposes, Archer first considered the substance and intent of entering into the United Agreements. Consistent with the intent of Milestone One, Archer believes that the principal consideration of Milestone Two was to induce United to commit to a contingent purchase agreement for a new type of commercially viable aircraft from Archer, which provides valuable credibility to Archer to have such a prestigious customer and helps Archer achieve the announced merger with Atlas. Regardless of whether United participated in the financing transaction, as discussed further below, Archer’s ability to market the relationship with United under the United Agreements to other potential investors was its objective. The initial conversations with Atlas about a merger started on December 31, 2020, which was after Archer was already well into its negotiations with United to become an anchor customer.
On February 10, 2021, Archer and Atlas entered into a business combination agreement.
Next, Archer considered the contractual terms of the warrant agreement with respect to Milestone Two. As noted below, and consistent with Archer’s intent, United is able to vest in Milestone Two upon the closing of a financing transaction (see the definition below) even if
United is not provided the opportunity to participate in such a financing transaction. Archer recognizes that the warrant agreement states that if United is provided an opportunity to participate in a financing transaction as an investor, it is required to invest
$25 million in such a transaction in order to vest in Milestone Two. As discussed above, and despite this vesting condition potentially appearing contradictory, Archer’s objective was to provide United with a 10% ownership stake as a means to induce
United to enter into the United Agreements as a customer, which, as noted above, Archer believed gave it increased credibility and would allow Archer to successfully complete a SPAC transaction or other public offering of securities. The completion of such a transaction demonstrated increased value of the relationship with United, for which Archer was willing to issue the additional warrants associated with Milestone Two. Based upon such intent and the objectives of the two companies as discussed above, Archer believes that the intent of the issuance of warrants subject to Milestone Two was not associated with the financing arrangement or solely to induce United to invest in the offering. The vesting terms of the warrant agreement, specific to Milestone Two, are as follows:
“The
Company’s acquisition in a SPAC Transaction or other financing transaction undertaken in connection with (up to and including) an IPO or Direct Listing (“Financing Transaction”) in which United is afforded the opportunity to invest, and does invest, $25,000,000 (any such transaction, a “United Investment”), including but not limited to any private placement in public equity transaction consummated in connection with such SPAC Transaction….If the Company is party to a SPAC, IPO or Direct Listing
(a “Public Event”) and United is not provided the opportunity to make a United Investment up to and including in connection with such Public Event, then all such unvested Condition II Shares shall automatically become vested and exercisable immediately prior to, but conditioned upon, the closing of the Financing Transaction.”
Archer then considered United’s level of participation in the financing transaction and the terms under which it invested. While United was not obligated to participate in the financing transaction if Archer did not make available the opportunity to do so, United did, in fact, make an investment.
Specifically, United invested $25 million as part of a private financing transaction that is occurring concurrently with the merger with
Atlas, which represents approximately four percent (4%) of the total amount of the private financing transaction.
Archer does not believe that this amount represents such a significant proportion of the investment to warrant different terms than the other investors.
Furthermore, numerous investors (including United) participated in the financing transaction for a total investment of $600 million on the same terms
(e.g., the same price per share and other provisions), and none of the other investors (which included five investors with individual investments equal to or exceeding $25 million) received warrants in conjunction with their investment. Given the relative size of United’s investment and the ability to successfully attract other unrelated investors under the same terms (without issuing any warrants), Archer does not believe that any of the warrants issued to United were an inducement for United to specifically enter into (or “lead”) a financing transaction. Furthermore, Archer notes that the grant date fair value of the warrants associated with Milestone Two is approximately $39.1 million, which far exceeds United’s $25 million investment and would not reasonably reflect an element of the financing transaction, especially in light of the observable transaction terms that other unrelated investors received.
In summary, the customer relationship with United is the foundational piece of the United Agreements. United’s decision to invest was in support of the goals of that customer relationship. It is on that basis that Archer concluded that the warrant cost for Milestone Two should be recorded apart from the financing transaction, and as part of the customer relationship instead.
Based on the discussion above, Archer respectfully continues to believe that the warrants were issued to United solely due to its participation in the
United Agreements, coupled with the recognition of the increased value of the commercial relationship to successfully complete a
SPAC transaction, IPO or direct listing of shares. While Archer did consider whether any of the warrants associated with Milestone
Two were associated with the financing transaction in which United participated, Archer does not believe that such warrants reflect an element of the financing transaction for the reasons outlined above.
We note your response to comment 12. Although your Exhibit Index indicates that the consent of Duff & Phelps has been filed as Exhibit 23.3, we are unable to locate a clear statement therein as to the firm's consent to the discussion of its opinion and to being named in the registration statement.Rest of the question
Please refer to Rule 436 of the Securities Act of 1933 and Question 233.01 of the Compliance and Disclosure Interpretations for the Securities Act Rules.
The Company acknowledges the Staff’s comment and will file the revised consent of Duff & Phelps as an exhibit to AmendmentRead in the reply
No. 4 to the Registration Statement.
We hope that the foregoing has been responsive to the Staff’s comments. If you have any questions related to this letter, please contact our counsel, Christian O. Nagler (by telephone at (212) 446-4660 or by email at [email protected]) or Tamar Donikyan (by telephone at (212) 909-3421 or by email at [email protected]).
Also in this review: company letter, Jun 4, 2021, company letter, Aug 3, 2021